Request a FREE Sample of our FcRn Binding Kit!
Request a FREE Sample of our FcRn Binding Kit!
Limited Edition Golden Llama is here! Check out how you can get one.
Limited Edition Golden Llama is here! Check out how you can get one.
Request a FREE sample of our GMP products!
Request a FREE sample of our GMP products!
Human BAFF Protein, His,Flag Tag (Cat. No. BAF-H52D4) stimulates proliferation of mouse spleen cells. The EC50 for this effect is 1.97-2.90 ng/mL (Routinely tested).
Human BAFFR Protein, Fc Tag (Cat. No. BAR-H5257) captured on CM5 chip via Anti-human IgG Fc antibodies surface can bind Human BAFF Protein, His,Flag Tag (Cat. No. BAF-H52D4) with an affinity constant of 5.54 nM as determined in a SPR assay (Biacore T200) (Routinely tested).
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Telitacicept | RCT-18; RC-18; RCT18; RC18 | Approved | RemeGen Co Ltd | 泰爱 | Mainland China | Lupus Erythematosus, Systemic | RemeGen Co Ltd | 2021-03-09 | Myasthenia Gravis; Multiple Sclerosis, Relapsing-Remitting; Glomerulonephritis, IGA; Sjogren's Syndrome; Arthritis, Rheumatoid; Multiple Sclerosis; Lupus Nephritis; Neuromyelitis Optica; Lupus Erythematosus, Systemic | Details |
Belimumab | BmAb; GSK-1550188; HGS-1006 | Approved | Glaxosmithkline Plc | Benlysta, 倍力腾 | United States | Lupus Erythematosus, Systemic | Human Genome Sciences Inc | 2011-03-09 | Glomerulonephritis, Membranous; Leukemia, Lymphocytic, Chronic, B-Cell; Pulmonary Disease, Chronic Obstructive; Emphysema; Waldenstrom Macroglobulinemia; Sjogren-Larsson Syndrome; Lymphopenia; Rheumatic Diseases; systemic sclerosis-associated interstitial lung disease; Lupus Erythematosus, Systemic; Lung Diseases, Interstitial; Myasthenia Gravis; Antiphospholipid Syndrome; Lupus Nephritis; Scleroderma, Systemic; Graft vs Host Disease; Arthritis, Rheumatoid; Purpura; Myositis; Granulomatosis with Polyangiitis; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Rejection of renal transplantation | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Atacicept | TACI-Ig | Phase 3 Clinical | Zymogenetics Inc | Glomerulonephritis, IGA; Arthritis, Rheumatoid; Multiple Sclerosis; Lupus Nephritis; Optic Neuritis; Lupus Erythematosus, Systemic | Details |
Rozibafusp alfa | AMG-570; MEDI-0700 | Phase 2 Clinical | Amgen Inc | Arthritis, Rheumatoid; Lupus Erythematosus, Systemic | Details |
Tabalumab | LY-2127399 | Phase 2 Clinical | Eli Lilly And Company | Multiple Sclerosis, Relapsing-Remitting; Dermatomyositis; Arthritis, Rheumatoid; Autoimmune Diseases; Scleroderma, Systemic; Multiple Myeloma; Connective Tissue Diseases; Arthritis, Juvenile; Multiple Sclerosis; Lupus Erythematosus, Systemic; Kidney Failure, Chronic; Pemphigus | Details |
Povetacicept | ALPN-303; ALPN 30x | Phase 2 Clinical | Alpine Immune Sciences Inc | Purpura, Thrombocytopenic, Idiopathic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Myasthenia Gravis; Glomerulonephritis, IGA; Sjogren's Syndrome; Lupus Nephritis; Glomerulonephritis, Membranous; Lupus Erythematosus, Systemic; Anemia, Hemolytic, Autoimmune; Inflammation; Cytopenia; Glomerulonephritis | Details |
UBP-1213 | UBP-1213 | Phase 1 Clinical | Wuhan Huaxin Kangyuan Biomedicine Co Ltd, Shanghai Junshi Biosciences Co Ltd | Lupus Erythematosus, Systemic | Details |
Autologous CAR-T cell therapy expressing the BAFF-ligand | LMY-920; LUMT1A22 | Phase 1 Clinical | Luminary Therapeutics Inc | Sjogren's Syndrome; Scleroderma, Systemic; Multiple Myeloma; Lupus Erythematosus, Systemic; Lymphoma, Mantle-Cell | Details |
UBP1213sc | UBP1213sc | Phase 1 Clinical | Lupus Nephritis; Lupus Erythematosus, Systemic | Details |
This web search service is supported by Google Inc.